ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kentucky » Medical Oncology

Top Medical Oncology Prescribers in Kentucky

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DATTATRAYA PRAJAPATI MD

Medical Oncology

2,380

$744K

359
280 are 65+

19%
patients receiving schedule two controlled substances

Avg: 18%

20%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 16%

$313
Average prescription price

Avg: $501

JOHN RINEHART M.D.

Medical Oncology

1,184

$884K

96
68 are 65+

33%
patients receiving schedule two controlled substances

Avg: 18%

36%
patients receiving schedule three controlled substances

Avg: 19%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

19%
prescriptions for brand name drugs

Avg: 16%

$747
Average prescription price

Avg: $501

DON STEVENS M.D.

Medical Oncology

1,183

$740K

215
175 are 65+

16%
patients receiving schedule two controlled substances

Avg: 18%

20%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

14%
prescriptions for brand name drugs

Avg: 16%

$626
Average prescription price

Avg: $501

JEWRAJ MAHESHWARI MD

Medical Oncology

1,003

$702K

206
159 are 65+

13%
patients receiving schedule two controlled substances

Avg: 18%

17%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 16%

$700
Average prescription price

Avg: $501

THOMAS WOODCOCK M.D.

Medical Oncology

854

$262K

161
116 are 65+

19%
patients receiving schedule two controlled substances

Avg: 18%

17%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 16%

$307
Average prescription price

Avg: $501

MUNEEB CHOUDRY M.D.

Medical Oncology

799

$499K

153
124 are 65+

14%
patients receiving schedule two controlled substances

Avg: 18%

14%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 16%

$624
Average prescription price

Avg: $501

JOHN HAMM M.D.

Medical Oncology

786

$561K

145
104 are 65+

26%
patients receiving schedule two controlled substances

Avg: 18%

11%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 16%

$713
Average prescription price

Avg: $501

MOHAMMAD KHAN M.D.

Medical Oncology

784

$156K

146
115 are 65+

14%
patients receiving schedule two controlled substances

Avg: 18%

8%
patients receiving schedule three controlled substances

Avg: 19%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

9%
prescriptions for brand name drugs

Avg: 16%

$199
Average prescription price

Avg: $501

RATILAL GAJERA M.D.

Medical Oncology

766

$510K

188
146 are 65+

9%
patients receiving schedule two controlled substances

Avg: 18%

12%
patients receiving schedule three controlled substances

Avg: 19%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 16%

$666
Average prescription price

Avg: $501

PHILLIP DESIMONE MD

Medical Oncology

705

$385K

90
67 are 65+

38%
patients receiving schedule two controlled substances

Avg: 18%

28%
patients receiving schedule three controlled substances

Avg: 19%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

26%
prescriptions for brand name drugs

Avg: 16%

$546
Average prescription price

Avg: $501

VICKIE MORGAN M.D.

Medical Oncology

671

$161K

83
56 are 65+

0%
patients receiving schedule two controlled substances

Avg: 18%

13%
patients receiving schedule three controlled substances

Avg: 19%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

11%
prescriptions for brand name drugs

Avg: 16%

$239
Average prescription price

Avg: $501

DENNIE JONES MD

Medical Oncology

406

$171K

61
40 are 65+

21%
patients receiving schedule two controlled substances

Avg: 18%

30%
patients receiving schedule three controlled substances

Avg: 19%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

15%
prescriptions for brand name drugs

Avg: 16%

$421
Average prescription price

Avg: $501

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank